Karen Kreeger

Blocking autophagy -- the process of "self-eating" within cells -- is turning out to be a viable way to enhance the effectiveness of a wide variety of cancer treatments.

Gene therapy for congenital blindness has taken another step forward, as researchers further improved vision in three adult patients previously treated in one eye. After receiving the same treatment in their other eye, the patients became better able to see in dim light, and two were able to navigate obstacles in low-light situations. No adverse effects occurred.

The molecular pathway that carries time-of-day signals from the body's internal clock to ultimately guide daily behavior is like a black box, says Amita Sehgal, PhD, the John Herr Musser Professor of Neuroscience and Co-Director, Comprehensive Neuroscience Center, at the

The Perelman School of Medicine at the University of Pennsylvania is one of six institutions to be named part of the National Heart, Lung, and Blood Institute’s Lung Repair and Regeneration Consortium (LRRC). Each of the institutions will receive $2.5 million over five years.

PHILADELPHIA - Four faculty members at the University of Pennsylvania have been named Fellows of the American Association for the Advancement of Science.  Three from Penn’s Perelman School of Medicine and one from its School of Arts and Sciences

PHILADELPHIA - James Eberwine, PhD, professor of Pharmacology, at the Perleman School of Medicine at the University of Pennsylvania, has received a

PHILADELPHIA – Greening of vacant urban land may affect the health and safety of nearby residents, according to a study published online in the American Journal of Epidemiology this week.

PHILADELPHIA - By studying tumor biology at the molecular level, researchers are gaining a deeper understanding of drug resistance - and how to avoid it by designing pediatric cancer treatments tailored to specific mutations in a child’s DNA.

PHILADELPHIA - The lining of the intestine regenerates itself every few days as compared to say red blood cells that turn over every four months. The cells that help to absorb food and liquid that humans consume are constantly being produced.

PHILADELPHIA - Scientists at Penn’s Perelman School of Medicine Center for Research in FOP and Related Disorders have developed a new genetic approach to specifically block the damaged copy of the gene for a rare bone disease, while leaving the normal copy untouched.